• Praeruptorin A: Applied Research Workflows

  2026-09-01

  Praeruptorin A is a multi-target angular pyranocoumarin compound for connecting ferroptosis, inflammation, epithelial-barrier, metastasis, and cardioprotection assays. This guide converts its reported dose ranges and pathway activities into practical workflows, controls, and troubleshooting decisions.

• 2-Thio-dCTP: A Precision Lens on Chromosome Stability

  2026-09-01

  Explore how 2-Thio-dCTP and 2-Thio-2'-deoxycytidine-5'-Triphosphate can sharpen DNA polymerase, site-specific modification, and DNA–protein interaction studies inspired by new SCP4 chromosome-stability findings.

• BVDV Glycolytic Reprogramming and RIG-I Evasion

  2026-08-31

  Li et al. identify a ROS–HIF-1α–glycolysis pathway that enables bovine viral diarrhea virus (BVDV) to weaken RIG-I/MAVS signaling and increase viral replication. The study connects HK2–MAVS–VDAC1 complex formation and lactate-mediated disruption of MAVS localization to impaired type I interferon production, providing a mechanistic framework for studying viral metabolic immune evasion.

• Flavopiridol Workflows for CDK and ER-Stress Studies

  2026-08-30

  Build more interpretable cell-cycle and apoptosis experiments with Flavopiridol, using dose-range design, orthogonal readouts, and parallel ER-stress controls. The workflow distinguishes direct CDK inhibition from tunicamycin-driven injury, helping cancer research teams translate intestinal stem-cell findings without overstating the evidence.

• SMPD4, Ceramide, and Primary Cilia in Brain Development

  2026-08-29

  The 2024 Development study identifies SMPD4-dependent ceramide production as a mechanistic requirement for primary-cilium formation, neural progenitor survival, and brain development. By combining a genetically altered mouse model with human SMPD4-deficient induced pluripotent stem cells and a ceramide-rescue experiment, the work connects sphingolipid metabolism to microcephaly and cerebellar hypoplasia.

• L-NAME Hydrochloride: Applied NOS Workflows

  2026-08-29

  L-NAME Hydrochloride provides a practical perturbation tool for separating nitric oxide synthase activity from downstream inflammatory and vascular phenotypes. This guide connects dose-controlled cell assays, vascular tone regulation studies, and reference-informed controls with troubleshooting strategies for more reproducible results.

• DeferoxamineB Workflows for Ferroptosis Studies

  2026-08-28

  DeferoxamineB provides a practical iron-chelation control for separating iron-dependent lipid damage from copper-driven and metabolism-linked tumor cell death. This workflow guide covers solution preparation, combination assays, quantitative readouts, and troubleshooting for cancer and oxidative-stress research.

• Cinoxacin as a Translational Assay Benchmark

  2026-08-28

  Cinoxacin is a quinolone antibiotic with a defined Gram-negative activity profile and practical value in urinary tract infection research. This article shows how to interpret its assay data alongside host-level clinical evidence without confusing antimicrobial susceptibility with immune recovery.

• Medroxyprogesterone acetate: Bench Workflow Guide

  2026-08-27

  Build reproducible MPA assays across reproductive, renal, and neurobiology models with solvent-aware dosing and receptor-mechanism controls. This guide connects a recent endometrial senescence study to practical experimental design without overstating what the reference directly tested.

• Rottlerin PKC Inhibitor: Workflows & Troubleshooting

  2026-08-27

  Use Rottlerin as a controlled PKCδ perturbation tool for connecting signaling changes with cell proliferation inhibition and apoptosis induction. This guide combines dose–time design, orthogonal validation, formulation-aware assay choices, and practical troubleshooting for cancer and endothelial research.

• Firefly Luciferase mRNA: Workflow & Optimization

  2026-08-26

  Build sensitive reporter assays with Cap1-capped, 5-moUTP-modified Firefly Luciferase mRNA for rapid expression profiling, delivery comparisons, and live-cell imaging. The workflow combines practical handling guidance with lessons from Pickering-emulsion vaccine research, while clearly separating product capabilities from delivery-system effects.

• PD0325901: Selective MEK Inhibition Guide

  2026-08-26

  PD0325901 is a selective MEK inhibitor that reduces phosphorylated ERK and alters cancer-cell proliferation, cell-cycle distribution, and survival in experimental systems. Product data also report tumor growth suppression in M14 and ME8959 mouse xenografts, while the AGO1 stem-cell study provides a separate mechanistic context that should not be treated as evidence of a direct PD0325901 effect.

• CPI-613 at the Mitochondria–Ferroptosis Interface

  2026-08-25

  CPI-613 is a lipoate-derived inhibitor of mitochondrial carbon metabolism that can sharpen apoptosis and ferroptosis-aware cancer assays. This article connects PDH-centered metabolic disruption with mitochondrial calcium–GPX4 biology while defining practical limits for interpreting cell-death results.

• Faropenem Transport via Renal Npt1

  2026-08-25

  This study identified the renal inorganic phosphate transporter Npt1 as a luminal transport pathway for faropenem, extending the transporter’s known organic-anion biology to penem antibiotics. Its oocyte experiments provide a mechanistic explanation for active renal secretion while also defining important limits for translating transporter data into infection or resistance models.

• Mitomycin C: A DNA-Damage Assay Compass

  2026-08-24

  Mitomycin C is an antitumor antibiotic that converts DNA damage into a measurable framework for cancer research and apoptosis signaling research. This article connects its mechanistic and handling variables with assay-design lessons from a CRISPR antiviral study without conflating the two experimental domains.

451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page